256 related articles for article (PubMed ID: 32045574)
1. HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia.
Zhang T; Tang X; Mao L; Chen J; Kuang J; Guo X; Xu D; Peng D; Yu B
Clin Biochem; 2020 May; 79():14-22. PubMed ID: 32045574
[TBL] [Abstract][Full Text] [Related]
2. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.
Guan Y; Hou X; Tian P; Ren L; Tang Y; Song A; Zhao J; Gao L; Song G
Front Endocrinol (Lausanne); 2021; 12():646185. PubMed ID: 33967959
[TBL] [Abstract][Full Text] [Related]
3. Estimating the fasting triglyceride concentration from the postprandial HDL-cholesterol and apolipoprotein CIII concentrations.
Kosuge K; Miida T; Takahashi A; Obayashi K; Ito M; Ito T; Soda S; Ozaki K; Hirayama S; Hanyu O; Aizawa Y; Nakamura Y
Atherosclerosis; 2006 Feb; 184(2):413-9. PubMed ID: 16024022
[TBL] [Abstract][Full Text] [Related]
4. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
[TBL] [Abstract][Full Text] [Related]
5. Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: the Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan.
Chang PY; Lee CM; Hsu HC; Lin HJ; Chien KL; Chen MF; Chen CH; Lee YT; Yang CY
Lipids Health Dis; 2012 Nov; 11():162. PubMed ID: 23173569
[TBL] [Abstract][Full Text] [Related]
6. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
Kypreos KE
Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
[TBL] [Abstract][Full Text] [Related]
7. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
[TBL] [Abstract][Full Text] [Related]
8. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.
Ding Y; Wang Y; Zhu H; Fan J; Yu L; Liu G; Liu E
Transgenic Res; 2011 Aug; 20(4):867-75. PubMed ID: 21120692
[TBL] [Abstract][Full Text] [Related]
10. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
[TBL] [Abstract][Full Text] [Related]
11. Possible risk factor for postmenopausal women: postprandial hypertriglyceridemia.
Yoshikata R; Miyahara Y; Onoe Y; Okano H; Ohta H
J Obstet Gynaecol Res; 2008 Dec; 34(6):1032-6. PubMed ID: 19012704
[TBL] [Abstract][Full Text] [Related]
12. The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it.
Xiong X; Liu H; Hua L; Zhao H; Wang D; Li Y
Lipids Health Dis; 2015 Oct; 14():127. PubMed ID: 26452348
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease.
Lee SJ; Moye LA; Campos H; Williams GH; Sacks FM
Atherosclerosis; 2003 Apr; 167(2):293-302. PubMed ID: 12818412
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism.
Luo M; Su X; Yi Y; Yang Y; Peng D
Lipids Health Dis; 2018 Jul; 17(1):160. PubMed ID: 30021607
[TBL] [Abstract][Full Text] [Related]
15. Hypoalphalipoproteinemia: postprandial response of subjects with preprandial normotriglyceridemia and hypertriglyceridemia to various diets.
Edelstein C; Fredenrich C; Schuelke JC; Jensen WE; Sitrin M; Iverius PH; Scanu AM
Metabolism; 1993 Feb; 42(2):247-57. PubMed ID: 8474323
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study.
Katzmann JL; Werner CM; Stojakovic T; März W; Scharnagl H; Laufs U
Lipids Health Dis; 2020 May; 19(1):116. PubMed ID: 32473635
[TBL] [Abstract][Full Text] [Related]
17. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
[TBL] [Abstract][Full Text] [Related]
18. Small HDL subclasses become cholesterol-poor during postprandial period after a fat diet intake in subjects with high triglyceridemia increases.
Quintanilla-Cantú A; Peña-de-la-Sancha P; Flores-Castillo C; Mejía-Domínguez AM; Posadas-Sánchez R; Pérez-Hernández N; Bautista-Pérez R; Enriquez-Calderón RE; Juárez-Oropeza MA; Fragoso JM; Vargas-Alarcón G; Pérez-Méndez O
Clin Chim Acta; 2017 Jan; 464():98-105. PubMed ID: 27847194
[TBL] [Abstract][Full Text] [Related]
19. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
Ebara T; Ramakrishnan R; Steiner G; Shachter NS
J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
[TBL] [Abstract][Full Text] [Related]
20. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.
Luo M; Liu A; Wang S; Wang T; Hu D; Wu S; Peng D
Sci Rep; 2017 May; 7(1):2312. PubMed ID: 28539597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
